LLY
Eli Lilly And Company Earnings
$906.49
Earnings Summary
Revenue | $19292Mn |
Net Profits | $6636Mn |
Net Profit Margins | 34.4% |
Eli Lilly And Company’s revenue jumped 42.56% since last year same period to $19292Mn in the Q4 2025. On a quarterly growth basis, Eli Lilly And Company has generated 9.61% jump in its revenue since last 3-months.
Eli Lilly And Company’s net profit jumped 50.48% since last year same period to $6636Mn in the Q4 2025. On a quarterly growth basis, Eli Lilly And Company has generated 18.87% jump in its net profits since last 3-months.
Eli Lilly And Company’s net profit margin jumped 5.56% since last year same period to 34.4% in the Q4 2025. On a quarterly growth basis, Eli Lilly And Company has generated 8.45% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 7.17 |
EPS Estimate Current Year | 7.17 |
Eli Lilly And Company’s earning per share (EPS) estimates for the current quarter stand at 7.17 - a 12.56% jump from last quarter’s estimates.
Eli Lilly And Company’s earning per share (EPS) estimates for the current year stand at 7.17.
Key Ratios
Earning Per Share (EPS) | 7.54 |
Dividend Per Share (DPS) | 1.5 |
Eli Lilly And Company’s earning per share (EPS) jumped 41.73% since last year same period to 7.54 in the Q4 2025. This indicates that the Eli Lilly And Company has generated 41.73% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Eli Lilly And Company declared 1.5 dividend per share during the earnings announcement for Q4 2025.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-07 | 5.59 | 6.31 | 12.88% |
2025-10-30 | 6.37 | 7.02 | 10.2% |
2026-02-12 | 7.17 | 7.54 | 5.16% |
2025-05-01 | 3.54 | 3.34 | -5.65% |





